Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Industry Segment
1.1.1.2. Technology Segment
1.1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective2
1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Industry and Technology Snapshot
2.3. End-use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing Focus on Water Testing
3.4.2. Legalization of Medical Cannabis and Growing Number of Cannabis Testing Laboratories
3.4.3. Increase in Outbreaks of Foodborne Illnesses
3.5. Market Restraint Analysis
3.5.1. High Capital Investment for Laboratory Proficiency Testing
3.6. Industry Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL Analysis
3.6.3. COVID-19 Impact Analysis
3.7. Market Opportunity Analysis, by Industry
3.7.1. Clinical Diagnostics
3.7.2. Pharmaceuticals
3.7.3. Microbiology
3.7.4. Cannabis
3.7.5. Others
Chapter 4. Industry Business Analysis
4.1. Laboratory Proficiency Testing Market: Industry Movement Analysis
4.2. Clinical Diagnostics
4.2.1. Clinical Diagnostics Market, 2018 – 2030 (USD Million)
4.2.2. Clinical Chemistry
4.2.2.1. Clinical Chemistry Market, 2018 – 2030 (USD Million)
4.2.3. Immunochemistry
4.2.3.1. Immunochemistry Market, 2018 – 2030 (USD Million)
4.2.4. Hematology
4.2.4.1. Hematology Market, 2018 – 2030 (USD Million)
4.2.5. Oncology
4.2.5.1. Oncology Market, 2018 – 2030 (USD Million)
4.2.6. Molecular Diagnostics
4.2.6.1. Molecular Diagnostics Market, 2018 – 2030 (USD Million)
4.2.6.2. PCR
4.2.6.2.1. PCR Market, 2018 – 2030 (USD Million)
4.2.6.3. Others
4.2.6.3.1. Others Market, 2018 – 2030 (USD Million)
4.2.7. Coagulation
4.2.7.1. Coagulation Market, 2018 – 2030 (USD Million)
4.2.8. Others
4.2.8.1. Others Market, 2018 – 2030 (USD Million)
4.3. Pharmaceuticals
4.3.1. Pharmaceuticals Market, 2018 – 2030 (USD Million)
4.3.2. Biological Products
4.3.2.1. Biological Products Market, 2018 – 2030 (USD Million)
4.3.2.2. Vaccines
4.3.2.2.1. Vaccines Market, 2018 – 2030 (USD Million)
4.3.2.3. Blood
4.3.2.3.1. Blood Market, 2018 – 2030 (USD Million)
4.3.2.4. Tissues
4.3.2.4.1. Tissues Market, 2018 – 2030 (USD Million)
4.3.3. Others
4.3.3.1. Others Market, 2018 – 2030 (USD Million)
4.4. Microbiology
4.4.1. Microbiology Market, 2018 – 2030 (USD Million)
4.4.2. Pathogen Testing
4.4.2.1. Pathogen Testing Market, 2018 – 2030 (USD Million)
4.4.3. Sterility Testing
4.4.3.1. Sterility Testing Market, 2018 – 2030 (USD Million)
4.4.4. Endotoxin & Pyrogen Testing
4.4.4.1. Endotoxin & Pyrogen Testing Market, 2018 – 2030 (USD Million)
4.4.5. Growth Promotion Testing
4.4.5.1. Growth Promotion Testing Market, 2018 – 2030 (USD Million)
4.4.6. Others
4.4.6.1. Others Market, 2018 – 2030 (USD Million)
4.5. Cannabis
4.5.1. Cannabis Market, 2018 – 2030 (USD Million)
4.5.2. Medical
4.5.2.1. Medical Market, 2018 – 2030 (USD Million)
4.5.3. Non-Medical
4.5.3.1. Non-Medical Market, 2018 – 2030 (USD Million)
4.6. Others
4.6.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5. Technology Business Analysis
5.1. Laboratory Proficiency Testing Market: Technology Movement Analysis
5.2. Cell Culture
5.2.1. Cell Culture Market, 2018 – 2030 (USD Million)
5.3. Spectrometry
5.3.1. Spectrometry Market, 2018 – 2030 (USD Million)
5.4. Polymerase Chain Reaction
5.4.1. Polymerase Chain Reaction Market, 2018 – 2030 (USD Million)
5.5. Chromatography
5.5.1. Chromatography Market, 2018 – 2030 (USD Million)
5.6. Immunoassays
5.6.1. Immunoassays Market, 2018 – 2030 (USD Million)
5.7. Others
5.7.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. Laboratory Proficiency Testing Market: End-use Movement Analysis
6.2. Hospitals
6.2.1. Hospitals Market, 2018 – 2030 (USD Million)
6.3. Contract Research Organizations
6.3.1. Contract Research Organizations Market, 2018 – 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 – 2030 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & Research Institutes Market, 2018 – 2030 (USD Million)
6.6. Laboratories
6.6.1. Laboratories Market, 2018 – 2030 (USD Million)
6.6.2. Independent Laboratories
6.6.2.1. Independent Laboratories Market, 2018 – 2030 (USD Million)
6.6.3. Specialty Laboratories
6.6.3.1. Specialty Laboratories Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Laboratory Proficiency Testing Market Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Framework
7.2.2.4. U.S. Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Framework
7.2.3.4. Canada Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. UK Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Germany Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. France Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Framework
7.3.5.4. Italy Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Framework
7.3.6.4. Spain Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Framework
7.3.7.4. Denmark Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Framework
7.3.8.4. Sweden Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Framework
7.3.9.4. Norway Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. Japan Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. China Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Framework
7.4.4.4. India Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Framework
7.4.5.4. Australia Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Framework
7.4.6.4. Thailand Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Framework
7.4.7.4. South Korea Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Brazil Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Mexico Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Argentina Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. MEA Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. South Africa Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Saudi Arabia Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. UAE Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Kuwait Laboratory Proficiency Testing Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2023
8.4. Company Profiles
8.4.1. LGC Limited
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Bio-Rad Laboratories, Inc
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Randox Laboratories
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. QACS – The Challenge Test Laboratory
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Merck KGaA
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Weqas
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. BIPEA
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. NSI Lab Solutions
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Absolute Standards, Inc.
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. INSTAND
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer